sulfinpyrazone and Thromboembolism studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.

Research Excerpts

Excerpt	Relevance	Reference
"To resolve questions of drug actions, efficacy, and interactions for platelet-modifying agents used clinically, we have compared the relative capacities and mechanisms of aspirin, dipyridamole, sulfinpyrazone, and dazoxiben to prevent arterial thromboembolism in a baboon model."	7.67	Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. ( Bjornsson, TD; Hanson, SR; Harker, LA, 1985)
"The Anturane Reinfarction Trial evaluated the effect of sulfinpyrazone (Anturane) (200 mg four times a day) vs placebo on cardiac mortality rates among patients recently recovered from an acute myocardial infarction."	5.05	The anturane reinfarction trial. ( Sherry, S, 1980)
"Aspirin has been shown to reduce the number of transient ischemic attacks (TIA), stroke and death in patients with multiple TIA."	3.75	Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. ( Turpie, AG, 1982)
"To resolve questions of drug actions, efficacy, and interactions for platelet-modifying agents used clinically, we have compared the relative capacities and mechanisms of aspirin, dipyridamole, sulfinpyrazone, and dazoxiben to prevent arterial thromboembolism in a baboon model."	3.67	Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. ( Bjornsson, TD; Hanson, SR; Harker, LA, 1985)
"Aspirin was administered in daily doses of 20 mg/kg, dipyridamole in daily doses of 2."	1.27	Effective antiplatelet drug concentrations in experimental arterial thromboembolism. ( Bjornsson, TD; Hanson, SR; Harker, LA, 1987)
"In patients with mitral valve prolapse, TE appears to occur very infrequently."	1.26	Platelet survival time and thromboembolism in patients with mitral valve prolapse. ( Rainwater, J; Steele, P; Vogel, R; Weily, H, 1979)

Timeframe	Studies, this research(%)	All Research%
pre-1990	65 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors	Studies
Pay, GF	1
Wallis, RB	1
Zelaschi, D	1
Burley, DM	1
Dalton, M	1
Giorgiades, E	1
Ginsburg, J	1
Bolte, HD	1
Tullio, D	1
Murray, PD	1
Garnic, JD	1
Bettmann, MA	1
Fabris, F	1
Casonato, A	1
Randi, ML	1
Schivazappa, L	1
Schiavinato, L	1
Girolami, A	1
Sherry, S	3
Packham, MA	1
Mustard, JF	1
Ordinas, A	1
Ludlam, CA	1
Allan, N	1
Blandford, RB	1
Dowdle, R	1
Bentley, NJ	1
Bloom, AL	1
Bouchier-Hayes, D	1
Hladovec, J	1
Shattil, SJ	1
Brass, LF	1
Fontanilles, F	1
Poliwoda, H	1
Verstraete, M	2
O'Grady, J	1
Bunting, S	1
Moncada, S	1
Fuster, V	4
Chesebro, JH	2
Sternon, J	1
Turpie, AG	1
Nenci, GG	2
Agnelli, G	2
Parise, P	2
Merante, F	1
Ballatori, E	2
Donner, L	1
Loeliger, EA	1
Steele, P	5
Rainwater, J	3
Croveri, G	1
Jobin, F	1
Loo, J	1
Harker, LA	7
Hanson, SR	3
Rubegni, M	1
Provvedi, D	1
Bellini, PG	1
Bandinelli, C	1
De Mauro, G	1
Deykin, D	1
Gurewich, V	1
Harker, L	1
Hirsch, J	1
Didisheim, P	2
Weiss, HJ	1
Hirsh, J	11
Dettori, AG	1
Pini, M	1
Quintavalla, R	1
Ostendorf, P	1
Gantmacher, ML	1
Weily, H	2
Vogel, R	2
Berrettini, M	1
Gent, M	5
Genton, E	10
Klimt, CR	1
Doub, PH	1
Doub, NH	1
Gallus, AS	1
Matt, EM	1
Gruber, UF	1
Davies, H	3
Ppppas, G	1
Swedenborg, J	1
Schwartz, SI	1
Ellis, J	1
Buchanan, M	1
Steele, PM	1
Bjornsson, TD	2
Resnekov, L	1
Chediak, J	1
Lewis, D	1
Kazmier, FJ	1
Weily, HS	3
Steele, PP	2
Pappas, G	1

Article	Year
[Role of antiaggregant platelet drugs in thromboembolism]. Giornale italiano di cardiologia, 1981, Volume: 11, Issue:8 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anti-Bacterial Agents; Aspirin; Cerebrova	1981
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes. Advances in prostaglandin, thromboxane, and leukotriene research, 1982, Volume: 10 Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas	1982
Pharmacology of platelet-affecting drugs. Circulation, 1980, Volume: 62, Issue:6 Pt 2 Topics: Animals; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Cyclic AMP; Dose-Response Re	1980
[Current clinical results of antiplatelet medication]. Sangre, 1984, Volume: 29, Issue:4-C Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Brain Ischemia; Coronary Disease; Dipyridamole; D	1984
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy]. Recenti progressi in medicina, 1980, Volume: 68, Issue:4 Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprof	1980
Antithrombotic drugs in relation to prostaglandin metabolism. Clinics in haematology, 1980, Volume: 9, Issue:3 Topics: Aspirin; Coronary Disease; Dipyridamole; Extracorporeal Circulation; Fibrinolytic Agents; Heparin; H	1980
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. Progress in clinical and biological research, 1982, Volume: 89 Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary	1982
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents]. L'union medicale du Canada, 1976, Volume: 105, Issue:8 Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents; Arterioscl	1976
Platelet function inhibitors: their clinical use. Advances in internal medicine, 1978, Volume: 23 Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease	1978
[Indications and uncertainties of antiaggregating agents]. La Revue du praticien, 1977, Dec-11, Volume: 27, Issue:57 Topics: Anticoagulants; Aspirin; Clofibrate; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregati	1977
Antiplatelet drugs in thromboembolism. Postgraduate medicine, 1979, Volume: 66, Issue:3 Topics: Anticoagulants; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Drug Therapy, Combination;	1979
Platelet inhibitors in the treatment of thrombosis. Clinical and investigative medicine. Medecine clinique et experimentale, 1978, Volume: 1, Issue:3-4 Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clof	1978
[Treatment with antiplatelet drugs. Current status of knowledge]. Recenti progressi in medicina, 1979, Volume: 67, Issue:3 Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans	1979
Antiplatelet agents: a review. Journal of the Royal Society of Medicine, 1979, Volume: 72, Issue:7 Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofi	1979
Critical evaluation of platelet-inhibiting drugs in thrombotic disease. Progress in hematology, 1975, Volume: 9 Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo	1975
Clinical trials in thrombosis: secondary prevention of myocardial infarction. Thrombosis and haemostasis, 1976, Feb-29, Volume: 35, Issue:1 Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prospe	1976
Antithrombotic drugs: part II. Drugs, 1976, Volume: 12, Issue:2 Topics: Anabolic Agents; Ancrod; Animals; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Fibr	1976
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts). The New England journal of medicine, 1975, Dec-04, Volume: 293, Issue:23 Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Diso	1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts). The New England journal of medicine, 1975, 12-11, Volume: 293, Issue:24 Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria	1975
Antithrombotic agents in coronary artery disease. Chest, 1986, Volume: 89, Issue:2 Suppl Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disea	1986
Clinical aspects of antiplatelet therapy. Seminars in hematology, 1985, Volume: 22, Issue:2 Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Femal	1985
Platelet inhibition in the management of thrombosis. Thrombosis et diathesis haemorrhagica, 1974, Sep-30, Volume: 32, Issue:1 Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamol	1974

Article	Year
Sulphinpyrazone in post-myocardial infarction. Report from the Anturan Reinfarction Italian Study. Lancet (London, England), 1982, Jan-30, Volume: 1, Issue:8266 Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Italy; Male;	1982
Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets. Folia haematologica (Leipzig, Germany : 1928), 1983, Volume: 110, Issue:4 Topics: Adult; Blood Platelets; Cell Survival; Clinical Trials as Topic; Combined Modality Therapy; Double-B	1983
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes. Advances in prostaglandin, thromboxane, and leukotriene research, 1982, Volume: 10 Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas	1982
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts). Mayo Clinic proceedings, 1981, Volume: 56, Issue:4 Topics: Anticoagulants; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coro	1981
[Platelet antiaggregants: review of the literature (author's transl)]. Revue medicale de Bruxelles, 1981, Volume: 2, Issue:5 Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggrega	1981
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. Progress in clinical and biological research, 1982, Volume: 89 Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary	1982
The anturane reinfarction trial. Circulation, 1980, Volume: 62, Issue:6 Pt 2 Topics: Aspirin; Blood Platelets; Death, Sudden; Female; Humans; Male; Myocardial Infarction; Placebos; Sulf	1980
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy]. Folia haematologica (Leipzig, Germany : 1928), 1975, Volume: 102, Issue:2 Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Rela	1975
Drug therapy: antiplatelet therapy (second of two parts). The New England journal of medicine, 1978, Jun-22, Volume: 298, Issue:25 Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical T	1978
Platelet inhibitors in the treatment of thrombosis. Clinical and investigative medicine. Medecine clinique et experimentale, 1978, Volume: 1, Issue:3-4 Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clof	1978
Critical evaluation of platelet-inhibiting drugs in thrombotic disease. Progress in hematology, 1975, Volume: 9 Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo	1975
Clinical trials in thrombosis: secondary prevention of myocardial infarction. Thrombosis and haemostasis, 1976, Feb-29, Volume: 35, Issue:1 Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prospe	1976
The current status of platelet suppressive drugs in the treatment of thrombosis. Thrombosis et diathesis haemorrhagica, 1975, Jun-30, Volume: 33, Issue:3 Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Surviva	1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts). The New England journal of medicine, 1975, Dec-04, Volume: 293, Issue:23 Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Diso	1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts). The New England journal of medicine, 1975, 12-11, Volume: 293, Issue:24 Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria	1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts). The New England journal of medicine, 1975, Dec-18, Volume: 293, Issue:25 Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrin	1975
Antithrombotic agents in coronary artery disease. Chest, 1986, Volume: 89, Issue:2 Suppl Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disea	1986
Clinical aspects of antiplatelet therapy. Seminars in hematology, 1985, Volume: 22, Issue:2 Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Femal	1985

Article	Year
Sex difference in antithrombotic effect of sulphinpyrazone. Lancet (London, England), 1982, Feb-20, Volume: 1, Issue:8269 Topics: Estradiol; Humans; In Vitro Techniques; Male; Sex Factors; Sulfinpyrazone; Thromboembolism	1982
[Benefits and dangers of preventive thinking in medicine--prevention of thromboembolism]. Der Internist, 1981, Volume: 22, Issue:2 Topics: Adult; Aspirin; Bandages; Blood Flow Velocity; Coumarins; Dextrans; Dihydroergotamine; Dipyridamole;	1981
Pharmacology of angioplasty and intravascular thrombolysis. AJR. American journal of roentgenology, 1982, Volume: 139, Issue:4 Topics: Angioplasty, Balloon; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Dextrans; Dipyrida	1982
Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphinpyrazone. Thrombosis and haemostasis, 1981, Dec-23, Volume: 46, Issue:4 Topics: Adult; Aged; Anticoagulants; beta-Thromboglobulin; Cell Survival; Disseminated Intravascular Coagula	1981
Drugs in the treatment of thrombo-embolic disease--part I. Irish medical journal, 1983, Volume: 76, Issue:2 Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Carotid Artery Diseases; Cerebrovasc	1983
[Is modern anti-aggregation therapy effective?]. Casopis lekaru ceskych, 1984, May-25, Volume: 123, Issue:21 Topics: Aspirin; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboemb	1984
The prevention of prosthetic valve thromboembolism. Uses and limitations of anti-platelet drugs. International journal of cardiology, 1983, Volume: 3, Issue:1 Topics: Anticoagulants; Aspirin; Bioprosthesis; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthe	1983
[Summary of the clinical papers on sulfinpyrazone (Anturan) under discussion with a preview of the current study program]. Wiener medizinische Wochenschrift. Supplement, 1980, Volume: 61 Topics: Aged; Arteriovenous Shunt, Surgical; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Huma	1980
[Present situation of therapy with platelet aggregation inhibitors]. Acta medica Austriaca. Supplement, 1982, Volume: 25 Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Middle Aged;	1982
Sex difference in circulating platelet aggregates and response to antiplatelet treatment. Thrombosis and haemostasis, 1982, Dec-27, Volume: 48, Issue:3 Topics: Aspirin; Female; Humans; Male; Platelet Aggregation; Sex Factors; Sulfinpyrazone; Thromboembolism	1982
[Treatment and prevention of thromboembolism with anti-aggregation drugs]. Vnitrni lekarstvi, 1981, Volume: 27, Issue:5 Topics: Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboembolism	1981
Sulfinpyrazone and thromboembolism. Circulation, 1981, Volume: 64, Issue:5 Topics: Humans; Sulfinpyrazone; Thromboembolism	1981
Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease. Circulation, 1980, Volume: 62, Issue:3 Topics: Atrial Fibrillation; Blood Coagulation; Blood Platelets; Cell Survival; Heart Valve Prosthesis; Huma	1980
[Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use]. Minerva cardioangiologica, 1980, Volume: 28, Issue:10 Topics: Aspirin; Blood Platelet Disorders; Brain Ischemia; Clofibrate; Coronary Disease; Dipyridamole; Human	1980
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention. The Journal of clinical investigation, 1979, Volume: 64, Issue:2 Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Blood Transfusion; Dipyridamole; D	1979
[Anti-platelet aggregating drugs in the prevention of thromboembolic diseases]. Minerva medica, 1975, May-12, Volume: 66, Issue:36 Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Cardiovascular Diseases; Cerebrovascular Diso	1975
Treating thromboembolic disease. Geriatrics, 1977, Volume: 32, Issue:10 Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Fibrinolytic Agents; Heart Valve Pros	1977
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions]. Der Internist, 1979, Volume: 20, Issue:11 Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Cerebrovascular Disorders	1979
Platelet survival time and thromboembolism in patients with mitral valve prolapse. Circulation, 1979, Volume: 60, Issue:1 Topics: Adult; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Chromium Radioisotopes; Female; Hu	1979
Platelet suppressant therapy in patients with prosthetic cardiac valves. Relationship of clinical effectiveness to alteration of platelet survival time. Circulation, 1979, Volume: 60, Issue:4 Topics: Aortic Valve; Blood Platelets; Cell Survival; Depression, Chemical; Female; Heart Valve Prosthesis;	1979
Inhibition of spontaneous platelet aggregation by sulfinpyrazone. Thrombosis and haemostasis, 1979, Aug-31, Volume: 42, Issue:2 Topics: Aged; Arteriosclerosis; Diabetes Mellitus; Double-Blind Method; Humans; Hyperlipidemias; Male; Middl	1979
[New specialties, registered in Austria. Anturane 200 mg dragees, regulator of platelet function]. Wiener klinische Wochenschrift, 1979, Nov-23, Volume: 91, Issue:22 Topics: Aspirin; Austria; Drug Interactions; Drug Tolerance; Pharmacopoeias as Topic; Platelet Aggregation;	1979
[Prevention of postoperative thromboembolic complications with subcutaneously administered small doses of heparin]. Fortschritte der Medizin, 1977, Mar-10, Volume: 95, Issue:10 Topics: Heparin; Humans; Injections, Subcutaneous; Postoperative Complications; Sulfinpyrazone; Thromboembol	1977
Platelet survival time following aortic valve replacement. Circulation, 1975, Volume: 51, Issue:2 Topics: Adult; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspirin; Blood Platelets; Ce	1975
Platelet adhesiveness. The Journal of surgical research, 1975, Volume: 19, Issue:2 Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Collagen; Dextrans; Endothelium; Fibrinogen; Hep	1975
Proceedings: Comparative effects of platelet suppressant drugs on platelet survival time. Thrombosis et diathesis haemorrhagica, 1975, Nov-15, Volume: 34, Issue:2 Topics: Blood Platelets; Cell Survival; Clofibrate; Dipyridamole; Humans; In Vitro Techniques; Sulfinpyrazon	1975
Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs. Thrombosis et diathesis haemorrhagica, 1975, Nov-15, Volume: 34, Issue:2 Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; In Vitro Techniques; Platelet Aggreg	1975
Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism. Postgraduate medicine, 1985, Volume: 78, Issue:1 Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Bioprosthesis; Blood Platelets; Coronary Disease; Dip	1985
Effective antiplatelet drug concentrations in experimental arterial thromboembolism. Thrombosis research, 1987, Nov-01, Volume: 48, Issue:3 Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Dipyridamole; Kinetics; Male; Papio; Sulfinpyrazone	1987
Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. The Journal of clinical investigation, 1985, Volume: 75, Issue:5 Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Cyclooxygenase Inhibitors; Dipyridamole; Drug Syne	1985
Platelets. Canadian Medical Association journal, 1973, Feb-17, Volume: 108, Issue:4 Topics: Aspirin; Blood Platelets; Dipyridamole; Humans; Sulfinpyrazone; Thromboembolism	1973
Platelet survival in patients with substitute heart valves. The New England journal of medicine, 1974, Mar-07, Volume: 290, Issue:10 Topics: Adenosine Diphosphate; Aortic Valve; Blood Platelets; Cell Survival; Chromium Radioisotopes; Collage	1974
Platelet survival in patients with rheumatic heart disease. The New England journal of medicine, 1974, Mar-07, Volume: 290, Issue:10 Topics: Adenosine Diphosphate; Aortic Valve Stenosis; Blood Platelets; Cell Survival; Chromium Radioisotopes	1974
Altered platelet function in patients with prosthetic mitral valves. Effects of sulfinpyrazone therapy. Circulation, 1970, Volume: 42, Issue:5 Topics: Adult; Blood Coagulation Disorders; Blood Platelets; Chromium Isotopes; Female; Heart Valve Prosthes	1970

sulfinpyrazone and Thromboembolism

Research Excerpts

Research

Studies (65)

Authors

Reviews

Trials

Other Studies